Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Journal of Dalian Medical University》 2008-03
Add to Favorite Get Latest Update

Possibility of VEGF as a marker to evaluate effectiveness of intervention therapy to hepatorcellular carcinoma

SONG Lei1,L Shen (1.Department of Oncology,2.Medical Center,the Second Affiliated Hospital of Dalian Medical University,Dalian 116027,China)  
[Objective] To explore the feasibility of VEGF as a marker to evaluate the effectiveness of transarterial chemoembolization (TACE) of HCC(hepatic cell cancer),and to study the correlation between the level of plasma VEGF level and biological characteristics of HCC.[Methods] Peripheral bloods were sampled at the 1st day before the therapy and at the 1st,3rd,7th,14th,and the 28th day after intervention therapy,respectively,from 13 patients with HCC receiving with TACE treatment.The quantitative sandwich enzyme-linked immunosorbent assay(ELISA) was used to detect the plasma VEGF level.Analysis on the relationship between plasma VEGF levels and hepatic biochemistry level,level of AFP,and index or the imageological features of HCC.[Results] The mean of Plasma VEGF levels at the 1st day before the TACE,at the 1st,3rd, 7th,14th,and the 28th day after the treatment were 284.97±73.60,534.38±130.17,398.13±92.42,363.33±64.42,434.68±77.67 and 374.77±140.46 respectively; VEGF level at the 1st day after the treatment was significantly higher than that before the treatment(P0.05),then it was decreasing gradually as observed on the 3rd and 7th day,and then increased slightly on the 14th day.Higher level of plasma VEGF was observed in patients complicated with tumor embolism in portal vein or with fistula between hepatic artery and portal vein,or patients with remote metastases,but without significant correlation to the site and staining of the tumor,or the presence or not of the coating membrane of the tumor(P0.05),without significant correlation to levels of AFP,GPT,AST,TB,ALB AND PLT(P0.05).Good therapeutic effects were observed in 8 out of 13 patients,with the other 5 patients with poor response,and significant difference existed between the two groups of patients concerning levels of plasma VEGF before treatment and on the 28th day after treatment(P0.05).Significant correlation existed between variation ratio of VEGR before and after treatment(calculated based on the formula of the 28th day/pretreatment×100%) and the deposit of iodized oil in the tumor(r=-0.644,P=0.017).[Conclusion] The level of plasma VEGF can be adopted as an early-stage,sensitive,efficient and AFP-independent marker on evaluation of therapeutic effect of intervention.
【CateGory Index】: R735.7
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 3 Hits
1 Wu Mengchao Wu DongEastern Hepatobiliary Surgery Hospital,Second Miliary Medical University,Shanghai 200438,China;Progress in comprehensive treatment of primary liver cancer[J];Oncology Progress;2005-05
2 XIANG Xin,LIU Zhi wei,GU Wan qing,et al.Department of hepatobiliary surgery,PLA General hospital,Beijing 100853,China);THE RELATIONSHIP BETWEEN THE TIME OF OPERATION AND THE EXPRESSION OF VEGF AND MVD IN TUMOR TISSUES FOLLOWING TACE[J];Journal of Hepatobiliary Surgery;2004-01
3 LIU Shu lin, QI Wei min, LI Bin, ZHANG Li jun (Department of Clinical Laboratory, Tang du Hospital, Fourth Military Medical University, Xi'an 710038,China);Study on the correlation of alpha fetoprotein half life and relapse or metastasis of primary hepatocellular carcinoma[J];Immunological Journal;2001-02
【Co-citations】
Chinese Journal Full-text Database 10 Hits
1 WEI Wei1,2, GUO Rong-Ping1,2, LI Jin-Qing1,2, XU Li1,2, SHI Ming1,2, ZHANG Ya-Qi1,21. Skate Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China 2. Department of Hepatobiliary Tumor, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P. R. China;Effects of Cetuximab Combined Erlotinib on Proliferation of Human Hepatocellular Carcinoma Cell Lines HepG2 and Bel-7402[J];Chinese Journal of Cancer;2008-04
2 ZHAO Hui-liu, HUANG Zhao-dong, LIU Zhi-min, LEI Kao-ning, HUANG Jin-lian(Department of clinical laboratory, The Affiliated Cancer Hospital of Guangxi Medical University, Nanning 530021, China);Clinical Value of Combined Detection of Serum CYFRA21-1,CA724 and AFP Levels in Patients with Primary Hepatic Carcinoma[J];Labeled Immunoassays and Clinical Medicine;2009-01
3 GUAN Bin,TANG Yong,HOU Ting-quan,et al.(Department of Radiology,Hechuan People's Hospital,Chongqing 401520,China);Clinical study of double intervention therapy for moderate or advanced liver cancer[J];Chongqing Medicine;2006-22
4 FANG Jian-lin, FENG Gan-sheng, TAO Hong-fang, WANG Yong, REN Jian-zhuang,ZHAO Hui,ZHENG Chuan-sheng Department of Radiology, Peking Union Medical College Hospital of Huazhong University of Science and Technology, Tongji Medical College, WuHan 430022 China;ATRA Combined with Transhepatic Arterial Chemoembolization for Walker-256 Transplanted Hepatocarcinoma in Wistar Rats[J];Contemporary Medicine;2009-11
5 LUO Jiang-hong,XU Lin-feng,ZHOU Jing-xing,et al.Department of Radiology,the Second Affiliated Hospital,Zhongshan University,Guangzhou 510120,P.R.China;Significance of Hepatic Arteriography and Embolization for Treating Hepatocellular Carcinoma Complicated with Inferior Vena Cava Tumor Thrombosis[J];Radiologic Practice;2006-11
6 Yu Lina, Ke Weimin, Li Xiaohe, et al .Department of Infectious Diseases, The Third Affiliated Hospital,Sun YatSen University, Guangzhou, 510630;Dynamics of the levels of alpha fetoprotein before the terminal phases of fatal chronic severe hepatitis B[J];Journal of Clinical Hepatology;2006-02
7 Zheng-Ping Xiong, Shu-Ren Yang, Zhao-Yu Liang, En-Hua Xiao, Xiao-Ping Yu,Shen-Ke Zhou and Zi-Shu Zhang, Department of Radiology , Hunan Provincial TumorHospital. Changsha 410006, China ;Department of Radiology, Xiangya Second Hospital of Central South Uni-versity, Changsha 410011, China;Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma[J];国际肝胆胰疾病杂志(英文版);2004-03
8 LI Yun-fu, LIANG Yong-ren, DENG Dong-hai, et al( Department of General Surgery, The People's Hospital of Qiaotou, Dongguan City, Guangdong 523523, China);Palliative resection and implanted with a drug delivery system of advanced primary hepatocellular carcinoma[J];Hainan Medical Journal;2005-10
9 XIAO Shuping;The Changes of Blood Oxygen Before and After Transcatheter Arterial Chemo-embolization in Patients with Hepatocellular Carcinoma[J];Journal of Nursing Science;2007-15
10 Sun Wei(Department of Oncology,Huaibei People's Hospital,Huaibei 235000,China);Clinical Analysis of Three_Dimensional Conformal Radiation Therapy of 25 Cases Liver Carcinoma[J];Journal of Basic and Clinical Oncology;2006-06
【Co-references】
Chinese Journal Full-text Database 9 Hits
1 QIN Dong-Chun1,2, WANG Hai-Ying3, MEI Yuan-Ding1, ZHANG Qin-Xian21Department of Clinical Laboratory, First Affiliated Hospital, 2Basic Medical College, Zhengzhou University, Zhengzhou 450052, China, 3Department of Clinical Laboratory, Henan Hospital of Traditional Chinese Medicine, Zhengzhou 450000, China;Change of immunological functions in patients with primary hepatocellular carcinoma[J];Journal of the Fourth Military Medical University;2007-20
2 WAN Cheng,CUI Fei,CHEN Bin,et al(Nanfang Hospital of Southern Medical University,Guangdong Guangzhou 510515,China);VEGF in Hepatocellular Carcinoma and Their Clinical Values[J];Hebei Medicine;2008-06
3 QI Yue-yong ZOU Li-guang DAI Shu-hua HUANG Xiao-bing HAN Ke-qiang ZHANG Qi-chuan CHEN Lin.Department of Radiology,Xinqiao Hospital,Third Military Medical University,Chongqing 400037,China;Hepatic VX2 tumor after portal vein occlusion in rabbits:evaluation with DSA[J];Journal of Interventional Radiology;2006-11
4 JI Dong-hua, WANG Feng, LI Cheng, LIU Yong-sheng, WANG Ning-fang, ZHAO Li-jun. Interventional Treatment Department, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;Hepatic cancer with arteovenous or arteroportal leak: hepatic arterial continuous elemene perfusion with retaining catheter[J];Journal of Interventional Radiology;2007-08
5 HAO Ming-zhi~(1*),LIN Hai-lan~1,YU Wen-chang~1,ZHENG Jian-xiong~1,ZHANG Kong-zhi~1,CHEN Jian-bin~1,CHEN Qi-zhong~1,CHEN Yun-bin~1,ZHENG Wei-sheng~2(1.Department of Interventional Radiology,Fujian Provincial Tumor Hospital,Fuzhou 350014,China;2.Department of Oncology,the 180th Hospital of PLA,Quanzhou 362000,China);Transcatheter arterial injection of ethanol and iodized-oil emulsion to treat hepatocellular carcinoma with arteriovenous fistula[J];Chinese Journal of Interventional Imaging and Therapy;2006-06
6 QI Yueyong,ZOU Liguang,HUANG Xiaobing,et al.Department of Radiology,Xinqiao Hospital,Third Military Medical University,Chongqing 400037,P.R.China;An Experimental Study of VEGF Expression of Hepatic VX2 Tumor after Portal Vein Occlusion[J];Journal of Clinical Radiology;2007-04
7 GUO Ji-gang, GUO Shun-lin, DU Fu-hui, WANG Wen-hui, WANG Lian-chu, CHANG Xiang-hui Department of Radiology, The First Affiliated Hospital of Lanzhou Medical College, Lanzhou 730000, China;The changes of serum vascular endothelial growth factor before and after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma[J];Journal of China Medical Imaging;2003-03
8 DAI Xu1,HAN Ming-jun2,SU Hong-ying1,ZHAO Zhong-chun1,FENG Bo1,ZHANG Xi-tong1,XU Ke1(1.Radiology Department of the First Affiliated Hospital of China Medical University,Shenyang 110001,China;2.Radiology Department of the Fifth Affiliated Hospital of Zhongshan Medical University,Zhuhai Guangdong 519000,China);Study of recurrence and metastatic patterns of hepatic cellular carcinoma after transcatheter arterial chemoembolization[J];Journal of China Medical Imaging;2004-11
9 YAN Kaili,XU Xiucai,REN Weihai,LI Qing,WU Zhiwei,XU Jingwei,ZHANG Cuiping,ZHAI Zhimin(Department of Central Experimental Laboratory,Anhui Provincial Hospital,Hefei 230000,China);Serum Vascular endothelial growth factors dection and its Clinic significance in tumour patients[J];Chinese Journal of Clinical Healthcare;2006-01
【Secondary Citations】
Chinese Journal Full-text Database 6 Hits
1 WANG Jingbing,FENG Gansheng,LIANG Huimin,et al.Department of Interventional Radiology,Xiehe hospital,Tongji Medical college,Huazhong Science and Technology University,Wuhan 430022;Percutaneous microwave coagulation therapy for malignant hepatic tumor:preliminary study[J];Radiologic Practice;2003-01
2 XIAO Enhua, HU Guodong, LIU Pengcheng,et al. Department of Hepatobiliary, Tumor Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou, Guangdong Province 510060, P.R.China;The Effect of Chemoembolization on nm23/ndpk Gene Expression of Primary Hepatocellular Carcinoma[J];Journal of Clinical Radilolgy;2000-11
3 LI Zhen, HU Daoyu, CHU Qian,et al. Department of Radiology, The Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province 430030, P. R. China;Experimental Observation of Hepatic Cell Cycle Alteration after Transarterial Chemoembolization for Hepatic Carcinoma[J];Journal of Clinical Radiololgy;2003-04
4 GONG Gaoquan, WANG Xiaolin, ZHOU Kangrong,et al. Department of Radiology, The Affiliated Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China;Metallic Stent Treatment of Portal Cancerous Thrombus in Primary Hepatic Carcinoma: A Report of 19 Cases[J];Journal of Clinical Radiololgy;2003-06
5 Wu Dalong,Qin Shukui,He Zeming, et al. The cancer center of PLA, 81st hospital, Nanjing 210002;Hepatic arterial embolization and chemotherapy with HPT ?containing regimen for the treatment of ad- vanced primary liver cancer-----A report on 41 patients[J];Chinese Clinical Oncology;1998-04
6 Qu Chuanzheng,Li Zhibao,Zhao Jian. (The Affiliated Hosp.of Ningxia Med.Coll.,Yinchuan);Analysis of 49 over 60-year elderly patients of primary liver cancer treated with medicine-infusion and embolization of common hepatic artery[J];NINGXIA MEDICAL JOURNAL;1999-08
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved